Pergolide — CAS 66104-22-1

Pergolide is a potent ergoline-derived dopamine receptor agonist used in the treatment of Parkinson's disease. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. Pergolide acts on D1 and D2 dopamine receptor subtypes and was used as adjunctive therapy with levodopa/carbidopa. It is also used in veterinary medicine for the treatment of equine Pituitary Pars Intermedia Dysfunction (PPID/Cushings disease).

• Parkinson's disease management as adjunct to levodopa
• Equine Cushing's disease (PPID) — veterinary pharmaceutical use
• Restless leg syndrome research applications
• Hyperprolactinemia (investigational dopaminergic use)

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support